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Abstract
Background: Complications after stroke have been associated with poor outcome. Modern stroke treatment might
reduce the occurrence of complications. The aim of this study was to investigate whether the frequency and type of
complications during the first week after stroke has changed in patients treated in a stroke unit in 2013 compared to 2003.
Methods: In total 489 patients in 2003 and 185 patients in 2013 with acute stroke were included and followed
prospectively for 1 week, examining the frequency of 12 predefined complications adjusted for severity of stroke. Informed
consent was given by all patients or their next of kin.
Results: Mean (SD) age was 77.2 (10.2) and 76.9 (8.5) in 2003 and 2013 respectively, P = 0.455. Severity of stroke, measured
by the Scandinavian Stroke Scale, was 39.5 (16.8) versus 37.0 (16.4), P = 0.011. After adjustment for stroke severity the results
showed an odds ratio of 0.64 for experiencing one or more complications in the 2013 cohort versus the 2003 cohort, P= 0.
035. The subgroup analysis showed that the reduction was only significant in the group with moderate stroke, with 74 %
experiencing one or more complications in 2003 compared to 45 % in 2013, P< 0.001. Progressing stroke and myocardial
infarction occurred significantly less frequent in 2013 than in 2003; the frequency of other complications remained
unchanged.
Conclusions: The risk of experiencing one or more complications has decreased from 2003 to 2013. The reduction was
most pronounced in patents with moderate stroke with a significant reduction in progressing stroke and myocardial
infarction.
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Background
The incidence of stroke seems stable, but the case fatality
has decreased in recent decades [1–3]. This trend has been
associated with better stroke care (e.g. stroke unit care) [4]
and improved preventative treatment of cardiovascular risk
factors [1, 3, 5]. Experiencing complications after stroke is,
on the other hand, associated with increased mortality and
length of hospital stay in acute stroke patients [6]. The
most common complications include fever, pain, progres-
sing stroke and infections, but complications such as
myocardial infarctions, pulmonary embolisms and cardiac
arrest may also occur [6–8]. Most complications have
their onset within the first week after stroke [9]. Disability
and mortality increase with an increasing number of
complications experienced, especially progressing stroke,
chest infections and other infections [10, 11].
One important consequence of stroke unit (SU) care
has been the prevention and early treatment of complica-
tions after stroke, especially those related to immobility
[12]. However, studies examining the frequency of compli-
cations early after stroke show great discrepancies, with
frequency of falls ranging from 2 to 25 % and pneumonia
from 9 to 22 % [6, 13]. Such inequalities could be caused
by inconsistent definitions of complications, case mix, dif-
ferences in the completeness of recording, or variation in
prevention and treatment of complications among
hospitals. Some of these variations might also reflect
changes in stroke characteristics and treatment over time.
Significant changes in recent decades include the
extended use of computer tomography and magnetic res-
onance imaging, making stroke diagnostics more precise
[14], and more frequent use of thrombolysis in acute
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treatment [15]. Improved physiological homeostasis and
early mobilization have also received attention [16].
No systematic studies have thoroughly investigated
whether the frequency of complications after stroke have
changed in patients treated in dedicated stroke units.
The stroke population has also changed in recent de-
cades with a greater proportion of mild strokes probably
due to better primary prevention [17]. Because severity
of stroke is found to be strongly associated with the risk
of complications [9], severity should be considered in
comparisons of the frequency of complications in stroke
patients over different periods.
The primary aim of this study was to assess the
changes in frequency of patients with complications in
the acute phase after stroke from 2003 to 2013, adjusted
for the severity of stroke. The secondary aims were to
assess the changes in complications within the different
severity groups and to assess how the different types of
complications changed from 2003 to 2013 after adjusting
for stroke severity.
Our primary hypothesis was that the frequency of pa-
tients with one or more complications has decreased over
the last decade in patients treated in a comprehensive SU.
Methods
Study design
This prospective observational study assessed the fre-
quency of complications during the first week after
stroke, in the SU at Trondheim University Hospital,
Norway in 2003 and 2013. The frequency of compli-
cations was compared between the 2003- and the
2013-cohort.
Sample
Patients with acute stroke defined by the World Health
Organization (except subarachnoid hemorrhage), treated
in the SU in Trondheim and admitted to hospital within
48 h after onset of symptoms (within 24 h for the 2003-
cohort) were eligible for inclusion. Patients were fit for
inclusion if they were able to understand the Norwegian
language and willing to sign informed consent. In keep-
ing with Norwegian consent procedures for patients un-
able to consent for themselves, such patients were also
included if their next of kin did not oppose participation.
Patients were excluded if they were transferred to an-
other unit or hospital during the first days or given pal-
liative care (not receiving standard SU treatment), or if
they had already been included in the project due to an
earlier stroke.
The project was approved by the Regional Committee
for Medical and Health Research Ethics in Norway (REC
no 2012/1236). The approval included access to data
from the 2003-cohort.
Study setting
All patients were treated in the same comprehensive SU
in 2003 and 2013. The SU emphasized a multidisciplin-
ary approach and mobilization to standing or sitting
position out of bed within the first 24 h after onset of
symptoms. The multidisciplinary team consisted of a
physician, a nurse, a physiotherapist, a speech therapist
and a member from the early supported discharge team,
including an occupational therapist.
Furthermore the treatment consisted of a standardized
acute medical treatment program according to the
Norwegian Guidelines [18]. Patients were systematically
observed and evaluated during the first 72 h, and all re-
ceived a CT scan within 24 h, preferably within 6 h, after
admission. ECG, oxygen saturation and routine blood
tests were performed at admission; other diagnostic pro-
cedures were performed when indicated. During the first
days in the SU, all patients went through a standardized
systematic observation and examination of neurologic
deficits, blood pressure level, cardiac and pulmonary dis-
orders, temperature, glucose level and fluid and electro-
lyte balance. The main differences from 2003 to 2013
were a change from intermittent observation 4 to 6
times a day by the nurses on duty in 2003 to continuous
monitoring for all patients during the first 24–48 h in
2013. These changes in monitoring procedures were also
present during mobilization.
Another difference was the use of thrombolysis in
2003 versus 2013. Thrombolysis was accepted for use in
stroke patients in Norway in 2003 [19]. In the initial
phase, it was only given to patients included in studies,
and within 3 h after stroke. Later, it has been approved
for clinical use, and has since 2008 been accepted for
use within 4.5 h after stroke.
Measures
In the 2003 cohort, 14 of the most commonly reported
medical complications after stroke were registered [9, 13].
Because the method for measuring troponin T had
changed from 2003 to 2013, this complication (elevated
Troponin T without MI) was difficult to compare. Pain
was also omitted from this study, because the recording of
pain was different between the two cohorts, leaving 12
comparable medical complications, listed and defined in
Table 1.
For each complication, the assessor had to consider
whether any of the complications did occur every day
during the first week after admission to hospital. An ex-
ception was made for body temperature, which was
measured only during the first 2 or 3 days and after that
only if there was any clinical suspicion of fever and as-
sumed to be normal otherwise. Severity of stroke was
assessed by Scandinavian Stroke Scale (SSS) both in
2003 and 2013. The SSS is a reliable scale well validated
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and simple to perform and therefore used in our study
both in 2003 and 2013 [20–22]. The score ranges from 0
to 58 points, where 0 points is the worst possible out-
come and 58 is the best and means normal score in all
ratings. Functions measured are consciousness, gaze,
motor function in affected arm, hand and foot, cognitive
function, language, facial palsy, and ability to move. The
score has good ability to assess the severity of a stroke
and to predict outcome [23, 24].
Procedure
One trained assessors in 2003 and five trained assessors in
2013 assessed patients arriving at the SU prospectively day-
by-day and performed all the registrations. In weekends
data was assessed retrospectively by asking the nurses on
duty if any complications had occurred, and by assessing
the results of the systematic observations of neurological
deficits, vital signs and physiological homeostasis in the
medical records. As a part of standard SU care, progression
of symptoms was assessed 4 to 6 times a day by the nurses
on duty and registered in the patient records. To ensure ex-
cellent inter-observer agreement in the clinic, all nurses at
the ward were very well trained in the scoring system. In
the present study, progression was obtained from the pa-
tient records and defined as >2 points decrease in sum
score from the first assessment after admission until the as-
sessment performed 72 h after stroke. This method of
evaluation was similar in 2003 and 2013. Furthermore,
meetings were held during the data collection period, to en-
sure that everyone followed the same procedure. “Day one”
of the registration was defined as the day of admission to
the SU. Patients hospitalized for less than one week were
contacted by telephone at the end of the week and asked if
they had experienced any of the relevant complications.
Patients who could not be reached by telephone were con-
sidered lost to follow-up.
Statistics
Proportions were analyzed using the Pearson chi
squared test. Confidence intervals for difference between
proportions were computed using the Newcombe
method as recommended [25]. The Mann–Whitney test
was used to compare continuous variables. Binary logis-
tic regression was used to compare the frequency of
complications adjusted for the severity of stroke by SSS-
score, thrombolysis and age as continuous variables. The
Cochran-Armitage test for trend, exact mid p version
[26] was used to analyze trends between the most com-
mon complications and groups of stroke severity. Statis-
tical analyses were performed in SPSS 21, Microsoft
Excel 2010 and in StatXact 10.
Results
In 2003, 664 patients with suspected stroke were admit-
ted to the SU between January 1, 2002 and May 15,
2003. All stroke patients entering the ward during this
16.5 month period were screened for inclusion, and 489
patients were included.
In 2013, 402 patients with suspected stroke were ad-
mitted to the SU during the inclusion period in 2013,
lasting from September 17, 2012 to December 13, 2013,
except for a few weeks during the holidays; hence the in-
clusion period covered 13 months. A final group of 185
patients contributed to the data sample. Of these, 158
(85.4 %) arrived in hospital within 24 h after symptom
onset. Ninety-four patients (50.8 %) were discharged
during the first week, and were contacted by telephone
to complete the registration. Two patients (1.1 %) were
not reached by telephone and considered lost to follow-
up, and we assumed that no new complications occurred
in these patients after discharge. The flow of patients is
shown in Fig. 1.
Table 1 Definition of complications
Progressing stroke Decrease of more than 2 point on the sum score
of the following: consciousness; gaze paresis;
arm, hand, or leg strength on the Scandinavian
Stroke Scale (SSS) from the first assessment after
admission to the assessment 72 h after stroke
Recurrent stroke New onset of focal or neurologic deficits that
cannot be attributed to the presenting lesion
and are consistent with World Health
Organization definition of stroke
Fever Temperature ≥38.0 °C at any time during the
first week
Seizures Clinical diagnosis of focal and/or generalized
seizure in a previously non-epileptic patient
Falls
Non-serious falls Any fall regardless of cause but without serious
injury





Clinical symptoms of UTI combined with positive
urine dipstick examination for nitrite and/or
pyuria
Chest infection Auscultatory respiratory crackles combined with
at least 1 of the following: temperature >38 °C,




At least 2 of the following: elevated troponin-T
values, chest pain without any other explanation,
changes in ECG consistent with MI
Pressure sores Any skin break or necrosis resulting from pressure




Clinical diagnosis of deep vein thrombosis
supported by ultrasound or venography
Pulmonary
embolism
Clinical diagnosis supported by computed
tomography scan or ventilation/perfusion scan
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Data from the Norwegian Stroke Register enabled
comparison of the 131 patients who were eligible but
missed for inclusion with those included in the 2013 co-
hort. Those missed for inclusion were in mean (SD) aged
79.9 (8.8) years, which was significantly older, P = 0.004,
with shorter length of stay (LOS) in hospital, mean (SD)
6.3 (6.7) days, P < 0.001. Their mean (SD) SSS-score was
higher, 39.8 (16.5) points, which was borderline signifi-
cant, P = 0.055. Categorization of SSS-score by severity
groups showed significantly more patients in the group of
very mild stroke among those missed for inclusion com-
pared with those included, 29.8 % versus 15.1 %, P = 0.002.
Table 2 Displays the baseline characteristics of the
2003 and 2013 cohorts, with a significant lower SSS
score and mean stay in hospital in the 2013 cohort than
in the 2003 cohort. The lower SSS score was caused by a
lower proportion with very mild strokes and a higher
proportion with moderate strokes in patients included in
the 2013 cohort compared with the 2003 cohort. The
frequency of prestroke risk factors remained unchanged,
except for medical treatment of hypertension which was
more common in 2013. Furthermore thrombolytic ther-
apy also increased significantly from 2003 to 2013.
Table 3 Shows the frequencies of the most common
complications in each stroke severity group. The tests
for trend showed that risk of each of these complica-
tions, with a possible exception for falls, increased with
increasing stroke severity. Recurrent stroke, seizures,
pressure sores and thromboembolisms were experienced
by less than 4 % of the patients in both cohorts.
Table 4 Shows the risk of complications in each stroke
severity group during the first week after stroke onset in
the 2003 and 2013 cohort. In all the stroke categories
very mild to severe, this risk was lower in 2013 com-
pared to 2003. This reduction was statistically significant
(P < 0.001), and most pronounced for moderate strokes,
where 73.9 and 44.8 % of the patients in 2003 and 2013,
respectively, experienced one or more complications.
Table 5 Shows the odds ratio for developing the most
frequent complications in 2013 compared to 2003 co-
hort, adjusted for age, thrombolysis and stroke severity.
Both progressing stroke and myocardial infarction (MI)
seem to occur less frequently in the 2013 cohort than
the 2003 cohort. In the 2013 cohort, MI was reported
for one patient only, and this patient had received
thrombolysis. Hence, we did not adjust for thrombolysis
in this case. The frequency has not changed significantly
for any of the other complications, and falls might even
tend to be more common in the 2013 cohort. The odds
ratio for risk of complications in 2013 compared with
2003, adjusted for age, thrombolysis and stroke severity,
was 0.64, P = 0.035.
Discussion
To our knowledge, this is the first study to show 10-year
time trends for complications in patients treated in a
dedicated comprehensive stroke unit. The study shows
that complications are still common in the acute phase
after stroke, but are generally less common in 2013 than
in 2003, also after adjusting for differences in stroke se-
verity between the two cohorts. The reduction in com-
plications was most pronounced in those with moderate
stroke. Regarding specific complications, the reduction
was significant for progressing stroke and myocardial
Fig. 1 Flow chart for inclusion of patients
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infarction. There was also a trend towards fewer chest
infections.
Despite an overall reduction in the risk of experiencing
one or more complications from 2003 until 2013, it
seems that prevention of complications was not im-
proved for patients with severe strokes or mild strokes.
However, patients with moderate strokes showed a 29 %
risk reduction over this period. One possible explanation
is the improved monitoring and stronger focus on
physiological homeostasis that has been implemented in
the ward over the past years, and an increased use of
thrombolysis. In the present study, the effect of
thrombolytic therapy on complication risk was assessed
by adjusting for thrombolysis in the regression analysis.
The significant decrease in progressing stroke particu-
larly in patients with moderate and severe stroke indi-
cates that early detection of risk and treatment of
progression might have improved considerably. It is a
strength in our study, that progression was defined and
assessed in the same way by well-trained nurses on duty
both in 2003 and in 2013. The inter-observer agreement
has shown to be quite good using this method and the
reduction observed reflects probably a real difference
[20]. Patients with moderate stroke seem to have the
most pronounced reduction of frequency of progressing
stroke. The reason for less reduction in the severe group
might be that progression of symptoms in this group
quite often is due to brain edema, which might not be
reduced by monitoring and better control of the physio-
logical homeostasis. Mild strokes on the other hand have
quite a low risk of progression and due to low number
of events it will be difficult to find differences in this
group. Hence, the patients with moderate stroke might
be the group where system factors like blood pressure,
oxygen saturation and temperature are likely to be of
most importance for progression. In a review from the
Cochrane Library they also found a trend towards re-
duced rate of neurological complications like progressing
stroke in stroke units with continuous monitoring which
is quite similar to our result [27]. However in the
Cochrane review no stratification by severity of the
stroke was performed.
Previous studies have found frequencies of progressing
stroke ranging from 11 to 43 % [28, 29]. The great vari-
ability in the reported incidence has different reasons.
One important reason is that it has been difficult to
construct precise definitions of exacerbations of a stroke
and various terms such as “progressive stroke”, “early
neurologic deterioration” or “stroke in evolution” have
been used and have not made studies of these condition
easier [30]. Furthermore the use of different scales, cut-off
values and time perspectives in the definitions makes con-
clusions and comparisons even more difficult [31]. Hence,
a consensus on the definition of progressing stroke is
needed to enhance further research within this field.
A significant decrease was also seen for acute MI,
from 22 cases (4.5 %) in 2003 to only one case (0.5 %) in
2013. This very low incidence makes it difficult to con-
clude on the association between MI and stroke severity
and to adjust for thrombolysis, as the single patient
Table 2 Characteristics and risk factors of all patients
2003 cohort (n = 489) 2013 cohort (n = 185) p-value
Women, n (%)a 256 (52.4) 88 (47.6) 0.268
Age, mean (SD)b 77.2 (10.2) 76.9 (8.51) 0.455
Infarction, n (%)a 443 (90.6) 161 (87.0) 0.176
Hemorrhage, n (%)a 46 (9.4) 24 (13.0) 0.176
Scandinavian Stroke Scale, mean (SD)b 39.5 (16.8) 37.0 (16.40) 0.011
Days hospital stay, mean (SD)b 15 (11.44) 8.5 (8.07) <0.001
Days hospital stay, medianb 12 6
Risk factors, n (%)a
Transitory ischemic attack 57 (11.7) 26 (14.1) 0.398
Previous stroke 108 (22.1) 45 (24.3) 0.536
Angina pectoris 86 (17.6) 25 (13.5) 0.200
Myocardial infarction 71 (14.5) 34 (18.4) 0.218
Atrial fibrillation 102 (20.9) 49 (26.5) 0.118
Diabetes 72 (14.7) 28 (15.1) 0.893
Medical treatment for hypertension 190 (38.9) 107 (57.8) <0.001
Thrombolysisc 0 30 (18.6) <0.001
aPearson chi-squared test was used for comparing dichotomous variables
bMann Whitney U-test was applied on the continuous data
cProportion of patients treated with thrombolysis of all patients with infarction
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Table 3 Frequency of and trend for the most common complications in the 2003 and 2013 cohort
2003 2013
Stroke severity n Fever Chest infection Prog. stroke MI UTI Falls n Fever Chest infection Prog. stroke MI UTI Falls
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Very severe 61 34 (55.7) 29 (47.5) 18 (29.5) 8 (13.1) 12 (19.7) 2 (3.3) 26 18 (69.2) 11 (42.3) 0 1 (3.8) 5 (19.2) 3 (11.5)
Severe 58 32 (55.2) 14 (24.1) 12 (20.7) 8 (13.8) 9 (15.5) 4 (6.9) 24 11 (45.8) 6 (25.0) 3 (12.5) 0 4 (16.7) 5 (20.8)
Moderate 111 23 (20.7) 4 (3.6) 41 (36.9) 4 (3.6) 31 (27.9) 20 (18.0) 58 10 (17.2) 1 (1.7) 1 (1.7) 0 8 (13.8) 10 (17.2)
Mild 124 19 (15.3) 7 (5.6) 13 (10.5) 1 (0.8) 20 (16.1) 10 (8.1) 49 5 (10.2) 0 3 (6.1) 0 5 (10.2) 3 (6.1)
Very mild 135 8 (5.9) 1 (0.7) 6 (4.4) 1 (0.7) 6 (4.4) 4 (3.0) 28 2 (7.1) 0 2 (7.1) 0 0 1 (3.6)
Total number 489 116 (23.7) 55 (11.2) 90 (18.4) 22 (4.5) 78 (16.0) 40 (8.2) 185 46 (24.9) 18 (9.7) 9 (4.9) 1 (0.5) 22 (11.9) 22 (11.9)
p-value for trenda <0.001 <0.001 <0.001 <0.001 0.001 0.34 <0.001 <0.001 0.46 0.070 0.025 0.091
Very severe: SSS = 0–14, severe: SSS = 15–29, moderate: SSS = 30–44, mild: SSS = 54–51, very mild: SSS = 52–59












receiving MI in 2013 received thrombolysis while none
of the patients in 2003 did. The method for measuring
Troponin T was changed between 2003 and 2013, but
the criteria for Troponin levels according to MI were
quite similar. Hence the reduction of MI is probably also
a real difference.
The significant decrease in the occurrence of MI is
supported by an Austrian study [32] carried out from
2006 to 2013, where MI was found in 1 % of stroke pa-
tients during hospital stay. Maintenance of physiologic
homeostasis is one important factor contributing to the
good outcome of SU care [16], and improvement in such
regulation might influence the risk of post-stroke MI.
Another important factor is continuous monitoring of
patients (ECG and oxygen saturation) which makes it
easier to detect signs of ischemia on the heart (atrial fib-
rillation and heart failure leading to hypoxia) [4], so that
prophylactic treatment can be initiated early in risk pa-
tients. A report from the Norwegian Institute of Public
Health shows that the incidence of first-time-MI is de-
creasing in the general elderly Norwegian population,
which possibly also has influenced our findings [33].
In the 2003 cohort fever, chest infections, progression
of stroke, MI and UTI occurred significantly more often
in patients with severe than with milder strokes but in the
2013 cohort such an association to severity occurred only
for fever, chest infection and UTI and a trend for MI while
progressing stroke had no such association to severity. For
MI with only one case, association to severity is not pos-
sible to assess. It is not possible to conclude whether the
reduction in frequency of progression of symptoms have
contributed to less association to severity of the stroke.
The use of thrombolysis in 30 patients (16 %) in 2013
versus no patients (0 %) in 2003 might have influenced
the complication rate. However, after adjusting for
thrombolytic therapy no significant changes were found.
Hence, thrombolytic therapy has probably not contributed
very much to the changes in complication rate between
2003 and 2013.
A major strength of this study was that patients were
followed up daily through a prospective design, minimiz-
ing the probability of omitting incidents of complica-
tions. Having a comparable cohort admitted to hospital
10 years ago reinforces the comparison, as the defini-
tions of complications were the same. The studies were
performed in the same SU which offers evidence-based
treatment according to the Norwegian guidelines.
The study had some limitations. Fewer patients were
screened for inclusion in 2013 compared to 2003. This
was due to a reduction in the entrance area and also to
a reduction in the number of beds for the SU at St.
Olavs Hospital between 2003 and 2013. Furthermore, a
considerable amount of patients were missed for inclu-
sion. LOS was significantly shorter in the 2013 cohort,
but those who were missed for inclusion in 2013 had an
even shorter LOS. Some patients with mild stroke were
discharged so rapidly that it was difficult to get time to
include them in the study. This probably explain why
there were significantly fewer patients with very mild
stroke in those included in 2013 than in those who were
missed. Hence, we cannot say that the differences in
stroke severity between our 2003 and 2013 cohort repre-
sent an actual difference in these populations. This is
Table 4 Frequency of and risk difference for developing complications according to stroke severity on admission
2003 2013
Stroke severity No. of patients One or more complications No. of patients One or more complications RD 95 % CI
n % n %
Very severe 61 50 82.0 26 24 92.3 −0.10 −0.23 to 0.08
Severe 58 45 77.6 24 16 66.7 0.11 −0.09 to 0.33
Moderate 111 82 73.9 58 26 44.8 0.29 0.43 to 0.14
Mild 124 50 40.7 49 13 26.5 0.14 −0.02 to 0.27
Very mild 135 25 18.4 28 5 17.9 0.01 −0.18 to 0.13
p-value for trenda <0.001 <0.001
Very severe: Scandinavian Stroke Scale (SSS) = 0–14, severe: SSS = 15–29, moderate: SSS = 30–44, mild: SSS = 54–51, very mild: SSS = 52–59
RD risk difference
aCochran-Armitage test for trend
Table 5 OR for development of complications in the 2013
cohort compared with the 2003 cohort
Complication OR 95 % CI for OR p-value
Fever 0.94 0.59 to 1.52 0.81
Chest infection 0.51 0.24 to 1.09 0.08
Progressing stroke 0.26 0.13 to 0.53 <0.001
MIa 0.09 0.01 to 0.70 0.02
UTI 0.64 0.36 to 1.13 0.12
Falls 1.56 0.88 to 2.79 0.13
One or more complicationsb 0.64 0.43 to 0.97 0.035
OR odds ratio, SSS Scandinavian stroke scale, MI myocardial infarction, UTI
urinary tract infection
aNot adjusted for thrombolysis
bRepresents all 12 complications
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taken into consideration by adjusting for stroke severity
in all analyses, as stroke severity strongly influences the
risk of experiencing complications in the acute phase.
Hence, we do not think the differences in stroke severity
influence the results very much. One should consider if
the shortened LOS and the follow-up by telephone in
2013 have limited the ability to capture some complica-
tions that might occur after discharge. However, most
complications occur within the first days after stroke [9],
and the follow-up via telephone was performed thor-
oughly by describing and asking for each complication
specifically, hence we do not believe that these features
have made a huge impact on our results.
Another limitation was that the time limit for arrival
in hospital after onset of symptoms was expanded from
24 h in 2003 to 48 h in 2013, to include sufficient pa-
tients in the study and increase the power. This in-
creases the risk of missing complications that occurs
after the stroke but before admission to hospital, as
these were not registered. This matter especially for pro-
gressing stroke and other temporary complications such
as falls and seizures; as most of the other complications
would still be present by admission and therefore be reg-
istered. However 85 % were admitted within 24 h and a
post hoc analysis showed almost identical results when
patients arriving after 24 h were excluded from the ana-
lyses, and this is considered not to have affected our re-
sults significantly.
Conclusion
Complications are still common in the acute phase after
stroke in patients treated in a comprehensive stroke unit.
However, after adjusting for age, thrombolysis and stroke
severity, the odds of experiencing one or more complica-
tions have decreased significantly from 2003 to 2013. The
reduction was greatest for progressing stroke and myocar-
dial infarction. Overall reduction in complications was
mainly seen for patients with moderate stroke. The reduc-
tion in complication rate cannot be explained by the intro-
duction of thrombolytic therapy but might be explained by
an increased focus on continuous monitoring and stabiliz-
ing physiological homeostasis over the past 10 years.
Abbreviations
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stroke unit; UTI, urinary tract infection
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